paclitaxel has been researched along with on 01910 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akula, B; Cosenza, SC; Hoffman, BS; Mallireddigari, MR; Pallela, VR; Reddy, EP; Reddy, MV; Robell, KA; Venkatapuram, P | 1 |
Abreu-Blanco, MT; Bindu, L; Durrant, DE; Holderfield, M; Morrison, DK; Ritt, DA; Specht, SI; Stephen, AG; Zhou, M | 1 |
2 other study(ies) available for paclitaxel and on 01910
Article | Year |
---|---|
Discovery of a clinical stage multi-kinase inhibitor sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): synthesis, structure-activity relationship, and biological activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Glycine; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones; Transplantation, Heterologous | 2011 |
Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit.
Topics: Enzyme Activation; Glycine; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Oxidative Stress; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; ras Proteins; Sulfones | 2016 |